CDI Global
Person name

Nicholas Hanser

CDI Global Member

Experience & Qualifications

Dr. Nicholas Hanser is Partner and Head of Technology Investment Banking at Saxenhammer & Co (Member of CDI Global B.V.)

Dr. Nicholas Hanser brings over 14 years of international corporate finance and Investment Banking experience with organizations such as Credit Suisse, Jefferies, BNP Paribas and Bryan Garnier based in Zurich, London, Frankfurt and Munich. He has led numerous transactions in the Technology and Healthcare space including most recently the IPO of Scout24 (€ 1.025m), the capital raises for MorphoSys (€ 115m) and Medigene (€ 48m) and the private placement for tado (US$ 50m). As a Partner and Head of Technology Investment Banking, his responsibilities at Saxenhammer & Co. include deal origination and execution, as well as the development of an efficient Technology Investment Banking team.

Nicholas holds a PhD in Economics and Management and a Masters in Management from ESCP Europe, as well as a Master of Science from Cass Business School in London. Nicholas specializes in the Technology and Healthcare sectors.

Connect with a CDI Expert. Request a Call Back.

News & Insights

Read more

January 17, 2021

M&A meets technology with CDI Global’s Agora platform

Read more

January 7, 2021

Webinar: Opportunities and Investment Trends in Healthcare – 2021

Divestitures: Overlooked Aspect of Active Portfolio Management
Commercial Aviation in Transition
CDI Global Italy Advises Strategic Purchase